// App-Quantinova.ai

THU0131 (2018) : Levels of cxcl13 and sicam1 correlate with disease activity score in rheumatoid arthritis (RA patients treated with tocilizumab (TCZ

Researchers

Presenter

  • T. Sornasse

Principal Investigators

  • C. Gabay

  • M. Townsend

  • R. Laubender

  • J. Wang

  • K. Tuckwell

Medical Centers

  • Genentech, Inc., South San Francisico, CA

  • University Hospital Geneva, Geneva, Switzerland

  • Roche Diagnostics GmbH, Penzberg, Germany

  • Roche Diagnostics, Welwyn Garden City, UK

Locations

  • United States

  • Switzerland

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • C-X-C Motif Chemokine Ligand 13

Drug/Treatment

  • Tocilizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved